Pharmopsis SRL
The score of Pharmopsis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -4 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmopsis's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −32,991 € | ||||
| Equity | 593,219 € | ||||
| Cash | 5,929 € | ||||
| EBITDA | 6,263 € | ||||
| Total assets | 698,486 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 26 Sep 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 14 Sep 2022
Pharmopsis's financial analysis
- Solvency84.9%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmopsis
Pharmopsis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.277.228
- VAT number
- BE0896277228
- Peppol
- Registered · 0208:0896277228 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Mar 2008
- Registered office
- 2000 Antwerp
- Latest accounts
- 2025 · filed on 24 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmopsis (SRL) has been based in Antwerp since 2008, active in: business and other management consultancy activities. For 2025, it reports a net loss of 32,991 € and equity of 593,219 €; its revenue is not published. Its solvency stands at 84.9%, above the median of its sector (58.4%).
Companies similar to Pharmopsis
Companies in the same business, of comparable size and area, outside its group.
- Matenwerk Business and other management consultancy activities Ghent · balance sheet 698,453 €
- ALU Home Creations Business and other management consultancy activities Kalmthout · balance sheet 698,812 €
- Nysto Business and other management consultancy activities Tielt · balance sheet 699,088 €
- TB Solutions Business and other management consultancy activities Uccle · balance sheet 697,755 €
- J DE Flander Business and other management consultancy activities Knokke-Heist · balance sheet 697,670 €
- KADEE Management Business and other management consultancy activities Lummen · balance sheet 699,494 €
- Trade Advising Business and other management consultancy activities Mouscron · balance sheet 697,404 €
- Ro-C Business and other management consultancy activities Antwerp · balance sheet 699,650 €
Frequently asked questions about Pharmopsis
What is the revenue of Pharmopsis?
Pharmopsis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmopsis?
In Belgium, the VAT number is the company number prefixed with BE: BE0896277228 for Pharmopsis, if the company is VAT-registered. Its company number (CBE) is 0896.277.228.
Where is the registered office of Pharmopsis?
According to the CBE register, the registered office of Pharmopsis is in 2000 Antwerp.
What is the equity of Pharmopsis?
At the close of the 2025 financial year, the equity of Pharmopsis amounts to 593,219 €, a solvency of 84.9% of total assets.
Who manages Pharmopsis?
The register lists 1 active mandates at Pharmopsis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmopsis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →